These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32195370)

  • 1. A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker.
    Masaki K; Tateno H; Nomura A; Muto T; Suzuki S; Satake K; Hida E; Fukunaga K
    NPJ Digit Med; 2020; 3():35. PubMed ID: 32195370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Smoking Cessation Smartphone App Integrated With a Mobile Carbon Monoxide Checker for Smoking Cessation Treatment: Protocol for a Randomized Controlled Trial.
    Nomura A; Tateno H; Masaki K; Muto T; Suzuki S; Satake K; Hida E; Fukunaga K
    JMIR Res Protoc; 2019 Feb; 8(2):e12252. PubMed ID: 30741641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Novel Smartphone App (CureApp Smoking Cessation) on Nicotine Dependence: Prospective Single-Arm Interventional Pilot Study.
    Masaki K; Tateno H; Kameyama N; Morino E; Watanabe R; Sekine K; Ono T; Satake K; Suzuki S; Nomura A; Betsuyaku T; Fukunaga K
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e12694. PubMed ID: 30777848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Telemedicine and Face-to-Face Consultation Based on the Standard Smoking Cessation Program for Nicotine Dependence: Protocol for a Randomized Controlled Trial.
    Tanigawa T; Nomura A; Kuroda M; Muto T; Hida E; Satake K
    JMIR Res Protoc; 2019 Jul; 8(7):e12701. PubMed ID: 31290402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial.
    Nomura A; Tanigawa T; Muto T; Oga T; Fukushima Y; Kiyosue A; Miyazaki M; Hida E; Satake K
    J Med Internet Res; 2019 Apr; 21(4):e13520. PubMed ID: 30982776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of a Comprehensive Mobile Smoking Cessation Program With Nicotine Replacement Therapy in Adult Smokers: Pilot Randomized Controlled Trial.
    Marler JD; Fujii CA; Utley MT; Balbierz DJ; Galanko JA; Utley DS
    JMIR Mhealth Uhealth; 2022 Nov; 10(11):e41658. PubMed ID: 36257323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and Acceptability of a Smoking Cessation Smartphone App (My QuitBuddy) in Older Persons: Pilot Randomized Controlled Trial.
    Peek J; Hay K; Hughes P; Kostellar A; Kumar S; Bhikoo Z; Serginson J; Marshall HM
    JMIR Form Res; 2021 Apr; 5(4):e24976. PubMed ID: 33851923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Smartphone App-Based Interventions for Assisting Smoking Cessation: Systematic Review and Meta-analysis.
    Guo YQ; Chen Y; Dabbs AD; Wu Y
    J Med Internet Res; 2023 Apr; 25():e43242. PubMed ID: 37079352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cognitive behavioural therapy-based smartphone app for smoking cessation in China: a study protocol of a randomised controlled trial.
    Liao Y; Tang J
    BMJ Open; 2021 Jan; 11(1):e041985. PubMed ID: 33441359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial.
    Webb J; Peerbux S; Smittenaar P; Siddiqui S; Sherwani Y; Ahmed M; MacRae H; Puri H; Bhalla S; Majeed A
    JMIR Ment Health; 2020 Oct; 7(10):e22833. PubMed ID: 33021488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Stop-tabac smartphone application for smoking cessation: a randomized controlled trial.
    Etter JF; Khazaal Y
    Addiction; 2022 May; 117(5):1406-1415. PubMed ID: 34738687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Smartphone App to Assist Smoking Cessation Among Aboriginal Australians: Findings From a Pilot Randomized Controlled Trial.
    Peiris D; Wright L; News M; Rogers K; Redfern J; Chow C; Thomas D
    JMIR Mhealth Uhealth; 2019 Apr; 7(4):e12745. PubMed ID: 30938691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a Text Message-Based Smoking Cessation Intervention for Adult Smokers in China: A Randomized Clinical Trial.
    Lin H; Liu Y; Zhang H; Zhu Z; Zhang X; Chang C
    JAMA Netw Open; 2023 Mar; 6(3):e230301. PubMed ID: 36857056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial.
    Lüscher J; Berli C; Schwaninger P; Scholz U
    BMC Public Health; 2019 Oct; 19(1):1400. PubMed ID: 31664959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Advice, Nicotine Replacement Therapy Sampling, and Active Referral for Expectant Fathers Who Smoke Cigarettes: A Randomized Clinical Trial.
    Luk TT; Lam TH; Leung WC; Leung KY; Cheung KW; Kwa C; Siong KH; Tang KK; Lee KW; Hsieh CJ; Wu YS; Li WH; Wang MP
    JAMA Intern Med; 2021 Aug; 181(8):1081-1089. PubMed ID: 34125135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mobile Just-in-Time Adaptive Intervention for Smoking Cessation: Pilot Randomized Controlled Trial.
    Hébert ET; Ra CK; Alexander AC; Helt A; Moisiuc R; Kendzor DE; Vidrine DJ; Funk-Lawler RK; Businelle MS
    J Med Internet Res; 2020 Mar; 22(3):e16907. PubMed ID: 32149716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation.
    Iacoviello BM; Steinerman JR; Klein DB; Silver TL; Berger AG; Luo SX; Schork NJ
    JMIR Mhealth Uhealth; 2017 Apr; 5(4):e56. PubMed ID: 28442453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.